Healthcare & Pharma
FDA Moves to Ban Compounded GLP-1 Drugs, Threatening TomorrowsRx Business Model
ViaNews Editorial Team (Markets)•
#GLP-1
2 articles
Pharmaceutical Sector
Pfizer Eyes GLP-1 Market Entry by 2028: What the Metsera Deal Means for Investors
ViaNews Editorial Team (Markets)•